Empagliflozin Mitigates Cardiac Remodeling and Heart Failure in Aortic Stenosis Rats
In a preclinical model of chronic pressure overload, eight weeks of empagliflozin treatment significantly reduced mortality, attenuated ventricular remodeling, and ...










